Kinetic inhibitory profile of BIA 3-202, a novel fast tight-binding, reversible and competitive catechol-O-methyltransferase inhibitor

By Bonifacio M.J.   Vieira-Coelho M.A.   Soares-da-Silva P.  

European Journal of Pharmacology, Vol. 460, Iss. 2, 2003-01 ,pp. : 163-170

Elsevier

Access to resources Recommend Favorite

Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-DOPA and dopamine in rats

By Napolitano A.   Zurcher G.   Da Prada M.  

European Journal of Pharmacology, Vol. 273, Iss. 3, 1995-02 ,pp. : 215-221

Elsevier

Access to resources Recommend Favorite

Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA Treatment

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 3, 2012-05 ,pp. : 251-263

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: A PET study with 6-[ 18 F]l-DOPA

By Doudet D.J.   Chan G.L.Y.   Holden J.E.   Pate B.D.   Morrison K.S.   Calne D.B.   Ruth T.J.  

European Journal of Pharmacology, Vol. 334, Iss. 1, 1997-09 ,pp. : 31-38

Elsevier

Access to resources Recommend Favorite

Inhibitors of Catechol-O-Methyltransferase

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 3, 2012-05 ,pp. : 324-332

Bentham Science Publishers

Access to resources Recommend Favorite